➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Express Scripts
Mallinckrodt
Johnson and Johnson
McKesson

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Meticillin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Meticillin?

Meticillin is an investigational drug.

There have been 5 clinical trials for Meticillin. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.

The most common disease conditions in clinical trials are Renal Insufficiency, Peritonitis, and Fibrosis. The leading clinical trial sponsors are Peter Bergman, Poitiers University Hospital, and University of Padova.

There is one US patent protecting this investigational drug and fifteen international patents.

Recent Clinical Trials for Meticillin
TitleSponsorPhase
Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF DeviceCentre Hospitalier Universitaire DijonPhase 2
Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) CarriersPeter BergmanPhase 2
Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal FailurePoitiers University HospitalPhase 3

See all Meticillin clinical trials

Clinical Trial Summary for Meticillin

Top disease conditions for Meticillin
Top clinical trial sponsors for Meticillin

See all Meticillin clinical trials

US Patents for Meticillin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Meticillin   Start Trial Cyclic boronic acid ester derivatives and methods of making the same Rempex Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
Meticillin   Start Trial Method of preparing carboxylic acid functionalized polymers NEKTAR THERAPEUTICS (San Francisco, CA)   Start Trial
Meticillin   Start Trial Cured gel and method of making ATRIUM MEDICAL CORPORATION (Merrimack, NH)   Start Trial
Meticillin   Start Trial Electrochemical activation of water GENEON TECHNOLOGIES LLC (San Antonio, TX)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Meticillin

Drugname Country Document Number Estimated Expiration Related US Patent
Meticillin Australia AU2011289615 2030-08-10   Start Trial
Meticillin Brazil BR112013003045 2030-08-10   Start Trial
Meticillin Canada CA2807546 2030-08-10   Start Trial
Meticillin Chile CL2013000399 2030-08-10   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Express Scripts
Mallinckrodt
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.